Skip to main content
Top
Published in: CardioVascular and Interventional Radiology 3/2006

01-06-2006

N-Nitrosodiethylamine-Induced Pig Liver Hepatocellular Carcinoma Model: Radiological and Histopathological Studies

Authors: Xiao Li, Xiangping Zhou, Yongsong Guan, Yi-Xiang J. Wang, Diane Scutt, Qi-Yong Gong

Published in: CardioVascular and Interventional Radiology | Issue 3/2006

Login to get access

Abstract

Experimental research involving animal models plays a critical role in the development and improvement of minimally invasive therapies for hepatocellular carcinoma (HCC). As a large animal, the pig is commonly used for surgery and interventional radiology research. In this study, liver multicentric HCC with cirrhosis was induced in six China Taihu pigs by intraperitoneal injection of 10 mg/kg of N-nitrosodiethylamine once a week for 3 months, followed by a period of 10–12 months without N-nitrosodiethylamine treatment. All pigs were in generally good health until the end of the study. The tumor nodules appeared hyperattenuating in the arterial phase of a dynamic computed tomography (CT) scan. Digital subtraction angiography (DSA) and CT angiography demonstrated that the tumors derived their blood supply mainly from the hepatic artery system. Lipiodol-CT showed Lipiodol retention in tumor areas. The histology and electron microscopic ultrastructure of the chemically induced liver HCC in this study resembled human HCC with a cirrhosis background. An immunohistochemistry study confirmed that the tumors were of hepatocyte origin. All highly, moderately, and poorly differentiated HCC tumors were identified in this study. Cholangiocarcinoma was not seen in any of the animals. Due to its comparable size to human anatomy, the pig liver HCC model would give a better scope for interventional and surgical manipulations than small animal models.
Literature
1.
go back to reference Parkin DM, Bray F, Ferlay J, et al. (2001) Estimating the world cancer burden: Globocan 2000. J Cancer 94:153–156 Parkin DM, Bray F, Ferlay J, et al. (2001) Estimating the world cancer burden: Globocan 2000. J Cancer 94:153–156
2.
go back to reference Bosch FX, Ribes J, Borras J (1999) Epidemiology of primary liver cancer. Semin Liver Dis 19:271–285PubMed Bosch FX, Ribes J, Borras J (1999) Epidemiology of primary liver cancer. Semin Liver Dis 19:271–285PubMed
3.
go back to reference Mazziotti A, Grazi GL, Cavallari A (1998) Surgical treatment of hepatocellular carcinoma on cirrhosis: A Western experience. Hepatogastroenterology 45(Suppl 3):1281–1287PubMed Mazziotti A, Grazi GL, Cavallari A (1998) Surgical treatment of hepatocellular carcinoma on cirrhosis: A Western experience. Hepatogastroenterology 45(Suppl 3):1281–1287PubMed
4.
go back to reference Chung JW (1998) Transcatheter arterial chemoembolization of hepatocellular carcinoma. Hepatogastroenterology 45(Suppl 3):1236–1241 PubMed Chung JW (1998) Transcatheter arterial chemoembolization of hepatocellular carcinoma. Hepatogastroenterology 45(Suppl 3):1236–1241 PubMed
5.
go back to reference Carr BI (2004) Hepatic arterial 90yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transplant 10(Suppl 1):S107–S110 Carr BI (2004) Hepatic arterial 90yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transplant 10(Suppl 1):S107–S110
6.
go back to reference Steel J, Baum A, Carr B (2004) Quality of life in patients diagnosed with primary hepatocellular carcinoma: Hepatic arterial infusion of Cisplatin versus 90-yttrium microspheres (Therasphere). Psychooncology 13:73–79PubMed Steel J, Baum A, Carr B (2004) Quality of life in patients diagnosed with primary hepatocellular carcinoma: Hepatic arterial infusion of Cisplatin versus 90-yttrium microspheres (Therasphere). Psychooncology 13:73–79PubMed
7.
go back to reference Ohnishi K, Yoshioka H, Ito S, et al. (1998) Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 27:67–72CrossRefPubMed Ohnishi K, Yoshioka H, Ito S, et al. (1998) Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 27:67–72CrossRefPubMed
8.
go back to reference Seki T, Wakabayashi M, Nakagawa T, et al. (1999) Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy. Cancer 85:1694–1702 CrossRefPubMed Seki T, Wakabayashi M, Nakagawa T, et al. (1999) Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy. Cancer 85:1694–1702 CrossRefPubMed
9.
go back to reference Shibata T, Iimuro Y, Yamamoto Y, et al. (2002) Small hepatocellular carcinoma: Comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 223:331–337 PubMed Shibata T, Iimuro Y, Yamamoto Y, et al. (2002) Small hepatocellular carcinoma: Comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 223:331–337 PubMed
10.
go back to reference Adam R, Hagopian EJ, Linhares M, et al. (2002) A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg 137:1332–1339PubMed Adam R, Hagopian EJ, Linhares M, et al. (2002) A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg 137:1332–1339PubMed
11.
go back to reference Pacella CM, Bizzarri G, Magnolfi F, et al. (2001) Laser thermal ablation in the treatment of small hepatocellular carcinoma: Results in 74 patients. Radiology. 221:712–720PubMed Pacella CM, Bizzarri G, Magnolfi F, et al. (2001) Laser thermal ablation in the treatment of small hepatocellular carcinoma: Results in 74 patients. Radiology. 221:712–720PubMed
12.
go back to reference Barajas M, Mazzolini G, Genove G, et al. (2001) Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12. Hepatology 33:52–61CrossRefPubMed Barajas M, Mazzolini G, Genove G, et al. (2001) Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12. Hepatology 33:52–61CrossRefPubMed
13.
go back to reference Schotman SM, Schraa EO, Marquet RL, et al. (1998) Hepatocellular carcinoma and liver transplantation: An animal model. Transplant Int 11(Suppl 1):S201–S205 Schotman SM, Schraa EO, Marquet RL, et al. (1998) Hepatocellular carcinoma and liver transplantation: An animal model. Transplant Int 11(Suppl 1):S201–S205
14.
go back to reference Labonte P, Kadhim S, Bowlin T, et al. (2000) Inhibition of tumor growth with doxorubicin in a new orthotopically implanted human hepatocellular carcinoma model. Hepatol Res 18:72–85PubMed Labonte P, Kadhim S, Bowlin T, et al. (2000) Inhibition of tumor growth with doxorubicin in a new orthotopically implanted human hepatocellular carcinoma model. Hepatol Res 18:72–85PubMed
15.
go back to reference Ni Y, Marchal G, Yu J, et al. (1993) Experimental liver cancers: Mn-DPDP-enhanced rims in MR–microangiographic–histologic correlation study. Radiology 188(1):45–51PubMed Ni Y, Marchal G, Yu J, et al. (1993) Experimental liver cancers: Mn-DPDP-enhanced rims in MR–microangiographic–histologic correlation study. Radiology 188(1):45–51PubMed
16.
go back to reference Bralet MP, Pichard V, Ferry N (2002) Demonstration of direct lineage between hepatocytes and hepatocellular carcinoma in diethylnitrosamine-treated rats. Hepatology 36:623–630CrossRefPubMed Bralet MP, Pichard V, Ferry N (2002) Demonstration of direct lineage between hepatocytes and hepatocellular carcinoma in diethylnitrosamine-treated rats. Hepatology 36:623–630CrossRefPubMed
17.
go back to reference Shah SS, Jacobs DL, Krasinkas AM, et al. (2004) Percutaneous ablation of VX2 carcinoma-induced liver tumors with use of ethanol versus acetic acid: Pilot study in a rabbit model. J Vasc Intervent Radiol 15:63–67 Shah SS, Jacobs DL, Krasinkas AM, et al. (2004) Percutaneous ablation of VX2 carcinoma-induced liver tumors with use of ethanol versus acetic acid: Pilot study in a rabbit model. J Vasc Intervent Radiol 15:63–67
18.
go back to reference Lapis K, Bocsi J, Timar F, et al. (1997) Studies on the proliferative activity of diethylnitrosamine-induced hepatocellular carcinomas in monkeys. J Pathol 181:439–443CrossRefPubMed Lapis K, Bocsi J, Timar F, et al. (1997) Studies on the proliferative activity of diethylnitrosamine-induced hepatocellular carcinomas in monkeys. J Pathol 181:439–443CrossRefPubMed
19.
go back to reference Graw JJ, Berg H (1977) Hepatocarcinogenetic effect of DENA in pigs. Z Krebsforsch Klin Onkol (Cancer Res Clin Oncol) 89:137–143 Graw JJ, Berg H (1977) Hepatocarcinogenetic effect of DENA in pigs. Z Krebsforsch Klin Onkol (Cancer Res Clin Oncol) 89:137–143
20.
go back to reference Gibson JB, Sobin LH (1978) Histological typing of tumors of the liver, biliary tract and pancreas. Pages 13–40 in International Histological Classification of Tumours. No. 20. Geneva: World Health Organization. Geneva Gibson JB, Sobin LH (1978) Histological typing of tumors of the liver, biliary tract and pancreas. Pages 13–40 in International Histological Classification of Tumours. No. 20. Geneva: World Health Organization. Geneva
21.
go back to reference Anderson CD, Lin WC, Beckham J, et al. (2004) Fluorescence spectroscopy accurately detects irreversible cell damage during hepatic radiofrequency ablation. Surgery 136:524–531CrossRefPubMed Anderson CD, Lin WC, Beckham J, et al. (2004) Fluorescence spectroscopy accurately detects irreversible cell damage during hepatic radiofrequency ablation. Surgery 136:524–531CrossRefPubMed
22.
go back to reference Lu DS, Sinha S, Lucas J, et al. (1997) MR-guided percutaneous ethanol ablation of liver tissue in a .2-T open MR system: Preliminary study in porcine model. J Magn Reson Imaging 7:303–308PubMed Lu DS, Sinha S, Lucas J, et al. (1997) MR-guided percutaneous ethanol ablation of liver tissue in a .2-T open MR system: Preliminary study in porcine model. J Magn Reson Imaging 7:303–308PubMed
23.
go back to reference Kinoshita A, Wanibuchi H, Morimura K, et al. (2003) Phenobarbital at low dose exerts hormesis in rat hepatocarcinogenesis by reducing oxidative DNA damage, altering cell proliferation, apoptosis and gene expression. Carcinogenesis 24:1389–1399CrossRefPubMed Kinoshita A, Wanibuchi H, Morimura K, et al. (2003) Phenobarbital at low dose exerts hormesis in rat hepatocarcinogenesis by reducing oxidative DNA damage, altering cell proliferation, apoptosis and gene expression. Carcinogenesis 24:1389–1399CrossRefPubMed
24.
go back to reference Park KA, Kweon S, Choi H (2002) Anticarcinogenic effect and modification of cytochrome P450 2E1 by dietary garlic powder in diethylnitrosamine-initiated rat hepatocarcinogenesis. J Biochem Mol Biol 35:615–622PubMed Park KA, Kweon S, Choi H (2002) Anticarcinogenic effect and modification of cytochrome P450 2E1 by dietary garlic powder in diethylnitrosamine-initiated rat hepatocarcinogenesis. J Biochem Mol Biol 35:615–622PubMed
25.
go back to reference Thirunavukkarasu C, Prince Vijeya Singh J, et al. (2002) Dietary influence of selenium on the incidence of N-nitrosodiethylamine-induced hepatoma with reference to drug and glutathione metabolizing enzymes. Cell Biochem Funct 20:347–356CrossRefPubMed Thirunavukkarasu C, Prince Vijeya Singh J, et al. (2002) Dietary influence of selenium on the incidence of N-nitrosodiethylamine-induced hepatoma with reference to drug and glutathione metabolizing enzymes. Cell Biochem Funct 20:347–356CrossRefPubMed
26.
go back to reference Minervini MI, Demetris AJ, Lee RG, et al. (1997) Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. Mod Pathol 10:686–692PubMed Minervini MI, Demetris AJ, Lee RG, et al. (1997) Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. Mod Pathol 10:686–692PubMed
28.
go back to reference Yamamoto Y, Moore R, Goldsworthy TL, et al. (2004) The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res 64:7197–7200PubMed Yamamoto Y, Moore R, Goldsworthy TL, et al. (2004) The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res 64:7197–7200PubMed
29.
go back to reference Weghorst CM, Pereira MA, Klaunig JE (1989) Strain differences in hepatic tumor promotion by phenobarbital in diethylnitrosamine- and dimethylnitrosamine-initiated infant male mice. Carcinogenesis 10:1409–1412PubMed Weghorst CM, Pereira MA, Klaunig JE (1989) Strain differences in hepatic tumor promotion by phenobarbital in diethylnitrosamine- and dimethylnitrosamine-initiated infant male mice. Carcinogenesis 10:1409–1412PubMed
Metadata
Title
N-Nitrosodiethylamine-Induced Pig Liver Hepatocellular Carcinoma Model: Radiological and Histopathological Studies
Authors
Xiao Li
Xiangping Zhou
Yongsong Guan
Yi-Xiang J. Wang
Diane Scutt
Qi-Yong Gong
Publication date
01-06-2006
Publisher
Springer-Verlag
Published in
CardioVascular and Interventional Radiology / Issue 3/2006
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-005-0099-8

Other articles of this Issue 3/2006

CardioVascular and Interventional Radiology 3/2006 Go to the issue